[Sedation with remifentanil for tracheostomy in a pediatric patient]

Area of Science:

• Anesthesiology
• Pediatric Critical Care
• Pharmacology

Background:

• Remifentanil is an ultra-short-acting opioid anesthetic commonly used in adults but less frequently in pediatric populations.
• Pediatric airway management presents unique challenges, especially in cases of significant anatomical distortion and bleeding risk.

Observation:

• A 7-year-old boy with lateral cervical tumors causing respiratory difficulty required an emergency tracheostomy.
• Due to intraoral tumor size, location, and bleeding history, conventional orotracheal intubation was contraindicated.
• The tracheostomy was performed under local anesthesia and sedation using a continuous infusion of remifentanil (0.05 mcg/kg/min).

Findings:

• Remifentanil provided adequate sedation, relaxation, and immobility for the surgical procedure.
• Spontaneous breathing was maintained throughout the procedure, consistent with recommended infusion rates for pediatric sedation.
• The risk of airway obstruction from bleeding was weighed against potential respiratory depression from remifentanil, with sedation deemed safer.

Implications:

• This case demonstrates the successful and safe use of remifentanil for sedation in a pediatric patient with a compromised airway.
• Remifentanil can be a valuable tool for airway management in children, particularly when maintaining spontaneous respiration is critical.
• Further research into remifentanil's role in pediatric procedural sedation and anesthesia is warranted.